FDA
approval
· 2025-05-14
FDA Approved: OLMESARTAN MEDOXOMIL AND AMLODIPINE BESYLATE AND HYDROCHLOROTHIAZIDE — Original Application (Slate Run Pharmaceuticals, LLC)
Summary
The FDA approved Slate Run Pharmaceuticals' generic fixed-dose combination of olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide under an origin…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for OLMESARTAN MEDOXOMIL AND AMLODIPINE BESYLATE AND HYDROCHLOROTHIAZIDE (OLMESARTAN MEDOXOMIL AND AMLODIPINE BESYLATE AND HYDROCHLOROTHIAZIDE)